English | 繁體

Search in the results

UM

Browse/Search Results:  1-8 of 8 Help

Selected(0)Clear Items/Page:    Sort:
Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia Journal article
Mo, Jianshan, Deng, Lin, Peng, Keren, Ouyang, Shumin, Ding, Wen, Lou, Linlin, Lin, Ziyou, Zhu, Jianzheng, Li, Jingwei, Zhang, Qiyi, Wang, Pengyan, Wen, Yuanzhen, Chen, Xiaobing, Yue, Peibin, Lu, Jin Jian, Zhu, Kai, Zheng, Yongjiang, Wang, Yuanxiang, Zhang, Xiaolei. Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia[J]. Journal of Hematology & Oncology, 2023, 16(1), 15.
Authors:  Mo, Jianshan;  Deng, Lin;  Peng, Keren;  Ouyang, Shumin;  Ding, Wen; et al.
Favorite | TC[WOS]:15 TC[Scopus]:14  IF:29.5/26.9 | Submit date：2023/03/06
Aml  Immunotherapy  Stat3 Inhibitor  Vista  
Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes Journal article
Liu, J., Yang, S., Cao, B., Zhou , G., Zhang, F., Wang, Y., Wang, R., Zhu, L., Meng, Y., Hu, C., Liang, H., Lin, X., Zhu, K., Chen, G., Luo, K.Q., Di, L., Zhao, Q.. Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes[J]. Journal of Hematology & Oncology, 2021, 14(1), 1-18.
Authors:  Liu, J.;  Yang, S.;  Cao, B.;  Zhou , G.;  Zhang, F.; et al.
Favorite | TC[WOS]:60 TC[Scopus]:64 | Submit date：2022/08/26
B7-h3  Chimeric Antigen Receptor  Bispecific Antibody  Non-small Cell Lung  
Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes Journal article
Liu, Jie, Yang, Shuo, Cao, Bihui, Zhou, Guangyu, Zhang, Fengjuan, Wang, Yuan, Wang, Rixin, Zhu, Lipeng, Meng, Ya, Hu, Cong, Liang, Hui, Lin, Xu, Zhu, Kangshun, Chen, Guokai, Luo, Kathy Qian, Di, Lijun, Zhao, Qi. Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes[J]. Journal of Hematology and Oncology, 2021, 14(1), 1-18.
Authors:  Liu, Jie;  Yang, Shuo;  Cao, Bihui;  Zhou, Guangyu;  Zhang, Fengjuan; et al.
Favorite | TC[WOS]:60 TC[Scopus]:64  IF:29.5/26.9 | Submit date：2021/03/04
B7-h3  Bike  Bispecific Antibody  Car t  Chimeric Antigen Receptor  Non-small Cell Lung Cancer  Pd-l1  
The emerging role of KDM5A in human cancer Review article
2021
Authors:  Yang,Guan Jun;  Zhu,Ming Hui;  Lu,Xin Jiang;  Liu,Yan Jun;  Lu,Jian Fei; et al.
Favorite | TC[WOS]:62 TC[Scopus]:67  IF:29.5/26.9 | Submit date：2021/03/01
Cancer  Drug Resistance  Histone Methylation  Jumonji c Domain  Kdm5a  Targeted Therapy  
Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort Journal article
Liu, Yun, Wang, Honglian, Wang, Xin, Liu, Jiaqi, Li, Junjian, Wang, Xiang, Zhang, Yun, Bai, Zhigang, Zhou, Qinghua, Wu, Ying, Shen, Yi, Weng, Xiaoling, Liu, Fatao, Guo, Jiancheng, Di, Lijun, Gires, Olivier, Zhang, Zhongtao, Chen, Yiding, Wang, Hongxia. Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort[J]. Journal of Hematology and Oncology, 2021, 14(1).
Authors:  Liu, Yun;  Wang, Honglian;  Wang, Xin;  Liu, Jiaqi;  Li, Junjian; et al.
Favorite | TC[WOS]:11 TC[Scopus]:19  IF:29.5/26.9 | Submit date：2022/05/13
Brca1/2  Breast Cancer  Cohort  Reclassification  Vus  
Erratum: The design and development of covalent protein-protein interaction inhibitors for cancer treatment (Journal of Hematology and Oncology (2020) 13 (26) DOI: 10.1186/s13045-020-00850-0) Other
2020-07-24
Authors:  Sha-Sha Cheng;  Guan-Jun Yang;  Wanhe Wang;  Chung-Hang Leung;  Dik-Lung Ma
Favorite | TC[WOS]:1 TC[Scopus]:1 | Submit date：2021/12/06
The design and development of covalent protein-protein interaction inhibitors for cancer treatment Review article
2020
Authors:  Cheng,Sha Sha;  Yang,Guan Jun;  Wang,Wanhe;  Leung,Chung Hang;  Ma,Dik Lung
Favorite | TC[WOS]:60 TC[Scopus]:65  IF:29.5/26.9 | Submit date：2021/03/01
Cancer Therapy  Covalent Inhibitors  Protein-protein Interaction  
Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery Journal article
Li, Ting, Jiang, Hu-Lin, Tong, Yun-Guang, Lu, Jin-Jian. Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery[J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11.
Authors:  Li, Ting;  Jiang, Hu-Lin;  Tong, Yun-Guang;  Lu, Jin-Jian
Favorite | TC[WOS]:42 TC[Scopus]:47  IF:29.5/26.9 | Submit date：2018/10/30
Hsp90 Chaperone Machinery  Cdc37  Kinase Client  Protein Interaction